A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients with Post-Operative Pain
|Effective start/end date||3/15/16 → 3/14/19|
- ACELRX PHARMACEUTICALS, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.